Regulus Therapeutics Inc.

NasdaqCM:RGLS

Market Cap

USD 545.56 M

Share Price

USD 7.88

Avg Daily Volume

2,047,107

Change (1 day)

-4.02%

Change (1 year)

212.70%

Change (YTD)

398.73%

Regulus Therapeutics Inc. Share Price Year-To-Date (YTD) return on June 20, 2025: 398.73%

Regulus Therapeutics Inc. Share Price Year-To-Date (YTD) return is 398.73% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.
  • Regulus Therapeutics Inc. 52-week low Share Price is USD 8.30 on June 20, 2025, which is 5.33% above the current Share Price.
  • Regulus Therapeutics Inc. 52-week low Share Price is USD 0.97 on June 20, 2025, which is -87.69% below the current Share Price.
  • Regulus Therapeutics Inc. average Share Price for the last 52 weeks is USD 2.50.
Key data
Date Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Price to Book Ratio (P/B) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqCM: RGLS

Regulus Therapeutics Inc.

CEO Mr. Joseph P. Hagan M.B.A.
IPO Date Oct. 9, 2012
Location United States
Headquarters 4224 Campus Point Court
Employees 34
Sector 🏥 Health Care
Industries
Description

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Similar companies

NOVO-B.CO

Novo Nordisk A/S

USD 73.32

-2.33%

ABBV

AbbVie Inc.

USD 185.30

-0.10%

RO.SW

Roche Holding AG

USD 336.78

-0.52%

ABT

Abbott Laboratories

USD 132.99

0.44%

NOVN.SW

Novartis AG

USD 115.96

-0.50%

AZN.L

AstraZeneca PLC

USD 140.24

-1.30%

MRK

Merck & Co., Inc.

USD 79.06

-0.29%

AMGN

Amgen Inc.

USD 289.33

-0.10%

PFE

Pfizer Inc.

USD 23.97

0.38%

GILD

Gilead Sciences, Inc.

USD 108.50

0.46%

SAN.PA

Sanofi

USD 95.88

0.36%

VRTX

Vertex Pharmaceuticals Incorporated

USD 440.87

-1.68%

BMY

Bristol-Myers Squibb Company

USD 46.86

0.04%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 49.19

-0.68%

GSK.L

GSK plc

USD 18.89

-2.25%

CSL.AX

CSL Limited

USD 154.82

0.08%

REGN

Regeneron Pharmaceuticals, Inc.

USD 509.72

-0.75%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 127.08

1.48%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.23

0.75%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.34

-0.64%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 309.70

-0.84%

UCB.BR

UCB SA

USD 181.46

0.14%

GEHC

GE HealthCare Technologies Inc.

USD 71.28

-0.85%

RGC

Regencell Bioscience Holdings Limited

USD 38.01

-40.00%

BAYN.DE

Bayer AG

USD 30.75

-0.65%

068270.KS

Celltrion, Inc.

USD 117.76

1.81%

2359.HK

WuXi AppTec Co., Ltd.

USD 9.39

0.82%

LH

Laboratory Corporation of America Holdings

USD 261.88

0.19%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.57

0.90%

RPRX

Royalty Pharma plc

USD 34.86

-0.14%

INSM

Insmed Incorporated

USD 102.68

3.24%

BIIB

Biogen Inc.

USD 127.04

0.40%

4503.T

Astellas Pharma Inc.

USD 9.25

-0.70%

1801.HK

Innovent Biologics, Inc.

USD 9.90

-0.96%

SMMT

Summit Therapeutics Inc.

USD 20.56

1.98%

4507.T

Shionogi & Co., Ltd.

USD 17.12

0.25%

GMAB.CO

Genmab A/S

USD 212.20

-1.53%

NBIX

Neurocrine Biosciences, Inc.

USD 126.55

-0.60%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 36.56

0.20%

EXEL

Exelixis, Inc.

USD 40.37

-0.91%

MANKIND.NS

Mankind Pharma Limited

USD 26.42

-1.47%

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.66

2.02%

BMRN

BioMarin Pharmaceutical Inc.

USD 55.00

-0.43%

ASND

Ascendis Pharma A/S

USD 176.90

3.63%

9926.HK

Akeso, Inc.

USD 11.63

-0.81%

LUPIN.NS

Lupin Limited

USD 22.49

0.94%

000963.SZ

Huadong Medicine Co., Ltd

USD 5.79

1.13%

IPN.PA

Ipsen S.A.

USD 116.25

-0.06%

SOBI.ST

Swedish Orphan Biovitrum AB (publ)

USD 28.19

-3.10%

StockViz Staff

June 22, 2025

Any question? Send us an email